vimarsana.com
Home
Live Updates
Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting : vimarsana.com
Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting
- Excellent Safety Profile, Stable Vision, and Reduced Frequency of Injections Observed for up to 6 months – - ODYSSEY Phase 2b Clinical Trial Enrollment is On Track with Data Expected in Q3...
Related Keywords
Texas ,
United States ,
Germany ,
Bulgaria ,
Rahul Khurana ,
George Lasezkay ,
Remy Bernarda ,
Jenny Kobin ,
Davidm Brown ,
Clearside Biomedical Inc ,
Retina Society ,
Retina International ,
Nasdaq ,
Exchange Commission ,
Globenewswire Inc ,
Safety Profile ,
Stable Vision ,
Reduced Frequency ,
Injections Observed ,
Clinical Trial Enrollment ,
Data Expected ,
Annual Scientific ,
Suprachoroidal Injection ,
Persistent Activity Following ,
Extension Study ,
Chief Executive ,
Diabetic Retinopathy ,
Tolerability Results ,
All Cohorts ,
Optical Coherence Tomography ,
Age Related Macular Degeneration ,
Socio Economic Impact ,
Private Securities Litigation Reform Act ,
Annual Report ,
Periodic Reports ,
Media Contacts ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.